shopping cart Your cart is empty
  • Home
  • Medical Devices
  • Nerve Monitoring Devices Market By Products (Monitors, Electrodes, Ancillary Products), By Technology (Somatosensory Evoked Potent...

Nerve Monitoring Devices Market By Products (Monitors, Electrodes, Ancillary Products), By Technology (Somatosensory Evoked Potentials, Electroencephalogram, Transcranial Electrical Motor Evoked Potentials, Brainstem Auditory Evoked Potentials, Visual Evoked Potentials, Electrocorticography), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: May 6, 2016

Key Findings


The global nerve monitoring market is expected to grow around $2.1 billion till 2022 with the CAGR of 9.2% during forecasted period of 2015-2022, the key factor that are thrusting up the market is rise in ageing population. As the population of aged people increases, simultaneously the demand is also increasing for for advanced healthcare equipment’s. According to WHO more than 37% of elder and aged peoples are suffering from chronic diseases which requires special attention. Apart from aged people, technological advancement is one of the major reason which is driving the global nerve monitoring market, as technology is also getting advanced in medical& bio engineering field accordingly. On the contrary, ancillary products such as abrasive gel, alcohol swabs, disposable sponge disks, and electrode creams are expected to witness massive growth over the forecast period. This can be attributed to increased usage of nerve monitoring systems and repeat purchase of these accessories.


Market Segment Insight


The market is majorly segmented on the basis ofproducts, technology and regional outlook. On the basis of products the market is divided into monitors, electrodes and ancillary products. In terms of technology the market is divided into Somatosensory Evoked Potentials, Electroencephalogram, Trans cranial Electrical Motor Evoked Potentials, Brainstem Auditory Evoked Potentials, Visual Evoked Potentials, Electromyography and Electrocorticography, in which Electrocorticography is having the largest market share in global nerve monitoring devices market which is approx. 63%. The global nerve monitoring devices is also segmented region wise which has North America, Europe, Asia pacific and rest of the world which including Saudi Arabia.


Regional Insight


Globally the nerve monitoring market is divided into North America, Asia Pacific, Europe and Rest of the World, in this the North America is having the largest market share due to technological advancement and advanced healthcare system. Apart from that favorable reimbursement coupled with rising disposable income is facilitating early and preventive diagnostics, thereby increasing the demand for nerve monitoring devices. Asia pacific is the fastest growing market and it’s expected to witness tremendous growth in future time. The presence of large untapped opportunities in emerging economies such as India, China and South Korea is anticipated to exhibit growth of this industry. Europe and rest of the world including Saudi Arabia also witness growth in near future.


Competitive Insights


Some of the keymarket players are, Nuvasive, Inc. Medtronic, Neurosign, Dr. Langer Medical GmbH, EMS Biomedical, Inomed,etc. Acquisitions, new product development, collaborations, joint ventures, mergers and expansions are the key strategies adopted by the market players to sustain in the market. Inomed introduces new software neuromonitoring called C2. The C2 spine software combines effectiveneuro monitoring in spine surger with the for simple, intuitive operation of the proven neuro monitoring device.

CHAP 1. METHODOLOGY & SCOPE 12
1.1. RESEARCH METHODOLOGY 12
1.2. RESEARCH SCOPE & ASSUMPTIONS 12
1.3. LIST OF DATA SOURCES 12


CHAP 2. EXECUTIVE SUMMARY 13
2.1. GLOBAL NERVE MONITORING DEVICES MARKETSUMMARY & KEY BUYING CRITERIA 13
2.2. GLOBAL NERVE MONITORING DEVICES MARKETOUTLOOK 13
2.3. MARKET SEGMENTATION ANALYSIS 13
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 13
2.5. GLOBAL NERVE MONITORING DEVICES MARKETVALUE CHAIN ANALYSIS 13
2.6. VENDOR LANDSCAPE 13


CHAP 3. GLOBAL NERVE MONITORING DEVICES MARKET 14
3.1. MARKET DRIVER ANALYSIS 14
3.1.1. ADVANCEMENT IN MEDICAL TECHNOLOGY 14
3.1.2. RISE IN AGEING POPULATION 14
3.2. MARKET RESTRAINT ANALYSIS 14
3.2.1. HIGH COST OF WEARABLE DEVICES 14
3.2.2. LESS ACCURACY/ PRECISION OF DATA 14
3.3. KEY OPPORTUNITIES 14
3.3.1. INCREASING DEMAND FOR NERVE OPERATING SYSTEM 14
3.3.2. INCREASING PENETRATION OF CHINESE TYRE 14
3.4. CHALLENGES 14
3.4.1. SECURITY CHALLENGES RELATED TO PATIENT 14


CHAP 4. INDUSTRY ANALYSIS 15
4.1. GLOBAL NERVE MONITORING DEVICES MARKET– PORTER’S FIVE FORCE MODEL 15
4.2. GLOBAL NERVE MONITORING DEVICES MARKET– PESTEL ANALYSIS 15
4.3. GLOBAL NERVE MONITORING DEVICES MARKET– GAP ANALYSIS 15


CHAP 5. GLOBAL NERVE MONITORING DEVICES MARKET BY PRODUCTS 2012-2022 ($ BILLION) 16
5.1. GLOBAL NERVE MONITORING DEVICES MARKET BY MONITORS TYRES 2012-2022 ($ BILLION) 16
5.2. GLOBAL NERVE MONITORING DEVICES MARKET BY ELECTRODES 2012-2022 ($ BILLION) 16
5.3. GLOBAL NERVE MONITORING DEVICES MARKET BY ANCILLARY PRODUCTS 2012-2022 ($ BILLION) 16


CHAP 6. GLOBAL NERVE MONITORING DEVICES MARKET BY TECHNOLOGY 2012-2022 ($ BILLION) 17
6.1. GLOBAL NERVE MONITORING DEVICES MARKET BY SOMATOSENSORY EVOKED POTENTIALS 2012-2022 ($ BILLION) 17
6.2. GLOBAL NERVE MONITORING DEVICES MARKET BY ELECTROENCEPHALOGRAM 2012-2022 ($ BILLION) 17
6.3. GLOBAL NERVE MONITORING DEVICES MARKET BY TRANSCRANIAL ELECTRICAL MOTOR EVOKED POTENTIALS 2012-2022 ($ BILLION) 17
6.4. GLOBAL NERVE MONITORING DEVICES MARKET BY BRAINSTEM AUDITORY EVOKED POTENTIALS 2012-2022 ($ BILLION) 17
6.5. GLOBAL NERVE MONITORING DEVICES MARKET BY VISUAL EVOKED POTENTIALS 2012-2022 ($ BILLION) 17
6.6. GLOBAL NERVE MONITORING DEVICES MARKET BY ELECTROMYOGRAPHY 2012-2022 ($ BILLION) 17
6.7. GLOBAL NERVE MONITORING DEVICES MARKET BY ELECTROCORTICOGRAPHY 2012-2022 ($ BILLION) 17


CHAP 7. GLOBAL NERVE MONITORING DEVICES MARKET REGIONAL OUTLOOK 2012-2022 ($ BILLION) 18
7.1. GLOBAL NERVE MONITORING DEVICES MARKET BY REGION 2012-2022 ($ BILLION) 18
7.2. NORTH AMERICA 18
7.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 18
7.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 18
7.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 18
7.2.3.1. U.S. 18
7.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 18
7.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 18
7.2.3.2. CANADA 18
7.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 18
7.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 18
7.3. EUROPE 18
7.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 18
7.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 18
7.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 18
7.3.3.1. GERMANY 18
7.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
7.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
7.3.3.2. UK 19
7.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
7.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
7.3.3.3. REST OF EUROPE 19
7.3.3.3.1. REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022($BILLION) 19
7.3.3.3.2. REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 19
7.4. ASIA PACIFIC 19
7.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
7.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 19
7.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
7.4.3.1. CHINA 19
7.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
7.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
7.4.3.2. INDIA 19
7.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
7.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
7.4.3.3. JAPAN 19
7.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
7.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION) 20
7.4.3.4. SOUTH KOREA 20
7.4.3.4.1. SOUTH KOREA MARKET ESTIMATES AND FORECASTS 2012-2022($BILLION) 20
7.4.3.4.2. SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 20
7.4.3.5. REST OF ASAP 20
7.4.3.5.1. REST OF ASAP MARKET ESTIMATES AND FORECASTS 2012-2022($BILLION) 20
7.4.3.5.2. REST OF ASAP MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 20
7.5. REST OF THE WORLD 20
7.5.1. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
7.5.2. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
7.5.3. SOUTH AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
7.5.4. SOUTH AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20


CHAP 8. COMPETITIVE LANDSCAPE 21
8.1. BOVIE MEDICAL 22
8.1.1. COMPANY OVERVIEW 22
8.1.2. SCOT ANALYSIS 22
8.1.3. PRODUCT BENCHMARKING 22
8.1.4. STRATEGIC INITIATIVES 22
8.2. BRAINSWAY 22
8.2.1. COMPANY OVERVIEW 22
8.2.2. SCOT ANALYSIS 22
8.2.3. PRODUCT BENCHMARKING 22
8.2.4. STRATEGIC INITIATIVES 22
8.3. CHECKPOINT SURGICAL 22
8.3.1. COMPANY OVERVIEW 22
8.3.2. SCOT ANALYSIS 22
8.3.3. PRODUCT BENCHMARKING 22
8.3.4. STRATEGIC INITIATIVES 22
8.4. DEYMED DIAGNOSTIC INC. 22
8.4.1. COMPANY OVERVIEW 22
8.4.2. SCOT ANALYSIS 22
8.4.3. PRODUCT BENCHMARKING 22
8.4.4. STRATEGIC INITIATIVES 22
8.5. DR. LANGER MEDICAL GMBH 22
8.5.1. COMPANY OVERVIEW 22
8.5.2. SCOT ANALYSIS 22
8.5.3. PRODUCT BENCHMARKING 22
8.5.4. STRATEGIC INITIATIVES 22
8.6. EMS BIOMEDICAL 22
8.6.1. COMPANY OVERVIEW 22
8.6.2. SCOT ANALYSIS 23
8.6.3. PRODUCT BENCHMARKING 23
8.6.4. STRATEGIC INITIATIVES 23
8.7. INOMED 23
8.7.1. COMPANY OVERVIEW 23
8.7.2. SCOT ANALYSIS 23
8.7.3. PRODUCT BENCHMARKING 23
8.7.4. STRATEGIC INITIATIVES 23
8.8. MAGTISM 23
8.8.1. COMPANY OVERVIEW 23
8.8.2. SCOT ANALYSIS 23
8.8.3. PRODUCT BENCHMARKING 23
8.8.4. STRATEGIC INITIATIVES 23
8.9. MEDTRONIC 23
8.9.1. COMPANY OVERVIEW 23
8.9.2. SCOT ANALYSIS 23
8.9.3. PRODUCT BENCHMARKING 23
8.9.4. STRATEGIC INITIATIVES 23
8.10. NATUS MEDICAL INC. 23
8.10.1. COMPANY OVERVIEW 23
8.10.2. SCOT ANALYSIS 23
8.10.3. PRODUCT BENCHMARKING 23
8.10.4. STRATEGIC INITIATIVES 23
8.11. NEUROSIGN 23
8.11.1. COMPANY OVERVIEW 23
8.11.2. SCOT ANALYSIS 23
8.11.3. PRODUCT BENCHMARKING 23
8.11.4. STRATEGIC INITIATIVES 23
8.12. NEUROSOFT 24
8.12.1. COMPANY OVERVIEW 24
8.12.2. SCOT ANALYSIS 24
8.12.3. PRODUCT BENCHMARKING 24
8.12.4. STRATEGIC INITIATIVES 24
8.13. NIHON KOHDEN CORPORATION 24
8.13.1. COMPANY OVERVIEW 24
8.13.2. SCOT ANALYSIS 24
8.13.3. PRODUCT BENCHMARKING 24
8.13.4. STRATEGIC INITIATIVES 24
8.14. NUVASIVE, INC. 24
8.14.1. COMPANY OVERVIEW 24
8.14.2. SCOT ANALYSIS 24
8.14.3. PRODUCT BENCHMARKING 24
8.14.4. STRATEGIC INITIATIVES 24
8.15. SYNEIKA 24
8.15.1. COMPANY OVERVIEW 24
8.15.2. SCOT ANALYSIS 24
8.15.3. PRODUCT BENCHMARKING 24
8.15.4. STRATEGIC INITIATIVES 24

TABLE 1 GLOBAL NERVE MONITORING DEVICES MAREKT BY PRODUCTS 2012-2022 ($ BILLION) 24
TABLE 2 GLOBAL NERVE MONITORING DEVICES MAREKT BY MONITORS TYRES 2012-2022 ($ BILLION) 24
TABLE 3 GLOBAL NERVE MONITORING DEVICES MAREKT BY ELECTRODES 2012-2022 ($ BILLION) 24
TABLE 4 GLOBAL NERVE MONITORING DEVICES MAREKT BY ANCILLARY PRODUCTS 2012-2022 ($ BILLION) 25
TABLE 5 GLOBAL NERVE MONITORING DEVICES MAREKT BY TECHNOLOGY 2012-2022 ($ BILLION) 25
TABLE 6 GLOBAL NERVE MONITORING DEVICES MAREKT BY SOMATOSENSORY EVOKED POTENTIALS 2012-2022 ($ BILLION) 25
TABLE 7 GLOBAL NERVE MONITORING DEVICES MAREKT BY ELECTROENCEPHALOGRAM 2012-2022 ($ BILLION) 25
TABLE 8 GLOBAL NERVE MONITORING DEVICES MAREKT BY TRANSCRANIAL ELECTRICAL MOTOR EVOKED POTENTIALS 2012-2022 ($ BILLION) 25
TABLE 9 GLOBAL NERVE MONITORING DEVICES MAREKT BY BRAINSTEM AUDITORY EVOKED POTENTIALS 2012-2022 ($ BILLION) 25
TABLE 10 GLOBAL NERVE MONITORING DEVICES MAREKT BY VISUAL EVOKED POTENTIALS 2012-2022 ($ BILLION) 25
TABLE 11 GLOBAL NERVE MONITORING DEVICES MAREKTBY ELECTROMYOGRAPHY 2012-2022 ($ BILLION) 25
TABLE 12 GLOBAL NERVE MONITORING DEVICES MAREKT BY ELECTROCORTICOGRAPHY 2012-2022 ($ BILLION) 25
TABLE 13 GLOBAL NERVE MONITORING DEVICES MAREKT REGIONAL OUTLOOK 2012-2022 ($ BILLION) 25
TABLE 14 GLOBAL NERVE MONITORING DEVICES MAREKT BY REGION 2012-2022 ($ BILLION) 25
TABLE 15 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 25
TABLE 16 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 25
TABLE 17 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 25
TABLE 18 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 25
TABLE 19 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 25
TABLE 20 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 25
TABLE 21 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 26
TABLE 22 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
TABLE 23 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 26
TABLE 24 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 26
TABLE 25 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
TABLE 26 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 26
TABLE 27 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
TABLE 28 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 26
TABLE 29 REST OF EUROPE MARKET ESTIMATES AND FORECAST2012-2022($BILLION) 26
TABLE 30 REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 26
TABLE 31 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
TABLE 32 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 26
TABLE 33 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 26
TABLE 34 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
TABLE 35 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 26
TABLE 36 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 26
TABLE 37 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 26
TABLE 38 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 27
TABLE 39 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION) 27
TABLE 40 SOUTH KOREA MARKET ESTIMATES AND FORECASTS 2012-2022($BILLION) 27
TABLE 41 SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 27
TABLE 42 REST OF ASAP MARKET ESTIMATES AND FORECASTS 2012-2022($BILLION) 27
TABLE 43 REST OF ASAP MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 27
TABLE 44 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 27
TABLE 45 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 27
TABLE 46 SOUTH AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 27
TABLE 47 SOUTH AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 27

FIGURE 1 MARKET SHARE BY REGIONS 27
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 27
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 27
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 27
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 27
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 27
FIGURE 7 REST OF EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 27
FIGURE 8 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 9 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 10 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 11 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 12 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 13 REST OF ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 14 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 15 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28
FIGURE 16 SOUTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 28

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)